Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
16 hedge funds and large institutions have $59.8M invested in Renalytix plc American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$36.1M |
| 2 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$12.3M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$5.68M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$4.83M |
| 5 |
Millennium Management
New York
|
+$4.23M |
Top Sellers
RNLX Hedge Fund Activity: Q3 2020 in Review
16 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q3 2020, worth a combined $59.8M.
Buyers outnumbered sellers: 16 funds opened new RNLX positions and 0 closed out — a net gain of 16 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $36.1M.
- 16 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $59.8M of Renalytix plc American Depositary Shares stock for Q3 2020.
- 16 funds opened new Renalytix plc American Depositary Shares positions in Q3 2020 and 0 closed out, a net change of +16 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q3 2020 was Gilder Gagnon Howe & Co, an estimated $36.1M added.
Based on aggregated 13F filings for Q3 2020.